NiCord®, umbilical cord blood-derived stem/progenitor cells for hemotological diseases

NiCord® is a graft of stem/progenitor cells isolated and expanded from a portion of a single unit of umbilical cord blood  and transplanted in combination with non-expanded cells. The portion of umbilical stem cells is expanded using Gamida Cell’s proprietary nicotinamide (NAM) technology, which leads to specific ex vivo expansion of functional CD34(+) cells. NiCord® is used to treat hematological malignancies and sickle cell disease and has been found to reduce the time of hematopoietic recovery and is capable of long term (>22 months) neutrophil and T-cell engraftment.